Revised cannabis penalties and QA rules were poised to be advanced at Wednesday’s board meeting and the WSLCB Director expanded on his testimony to the Legislature.
WSLCB Director Rick Garza spoke about restructuring agency enforcement and the Committee heard HB 2296 and HB 2300 regarding cannabidiol (CBD) products.
11 cannabis-related bills were scheduled for consideration in 5 committee meetings while the WSLCB planned action on Cannabis Penalties and Quality Control Testing rules.
Public hearings on cannabis-related bills HB 2263 and HB 2361 filled the hearing room to capacity, and generated significantly more resistance than promotion.
Board members received training from the Executive Ethics Board and discussed the addition of a second patient representative to the Cannabis Advisory Council.
New details on the WSLCB’s legislative agenda, a Regulators Roundtable redux, plus an update on testing labs, the traceability contract, and the Hillard Heintze report.
SBOH's legal counsel briefed on progress of a lawsuit against the agency over their authority to enact an emergency ban on flavored vapor products.
The Board reviewed the latest information on vapor associated lung injuries (VALI).
Washington state’s short legislative session begins today while the regulatory cadence at the WSLCB and Ecology continues apace.
The Board was treated to a sweeping survey of the agency’s prevention and public health efforts before a swift public hearing on the Cannabis Penalties rulemaking project.